Promising Results from Study on Celiac Disease Treatment
October 13, 2026
A clinical study of an experimental drug brings hope for those suffering from celiac disease, as it may limit damage from gluten in the small intestine. The drug FB102 showed positive results in participants exposed to gluten. Significant improvements were observed in the condition of the intestinal mucosa and other health indicators. Despite these positive findings, more studies are needed to determine the drug's safety and effectiveness. Until then, a strict gluten-free diet remains the primary treatment approach.